United States· US:0002-8715_75e52ccc-04da-4ae9-9a7b-23837ac3156a
Humulin
A medicinal product containing insulin human, registered in United States by Eli Lilly and Company.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- INSULIN HUMAN
- Manufacturer
- Eli Lilly and Company
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110002-8715-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulin human in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandHumulin I (Isophane) 100 IU/ml Suspension for Injection in cartridgeEli Lilly Nederland B.V.
- NetherlandsHumuline NPH KwikPen, suspensie voor injectie 100 IE/ml, 3 mlEli Lilly Nederland B.V.
- CzechiaACTRAPIDNovo Nordisk A/S, Bagsvaerd
- FinlandActrapidNovo Nordisk A/S
- PolandActraphane 30Novo Nordisk A/S
- GermanyBerlinsulin H Basal PenLilly Deutschland Gmbh
- United KingdomActrapid 100units/ml solution for injection 10ml vialsWaymade Healthcare Plc
- IcelandActrapidNovo Nordisk A/S*
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Huminsulin Basal Kwikpen, Huminsulin Basal Kwikpen Lilly
- Belgium · Humuline 30/70 Cartridge, Humuline Nph Cartridge
- Bulgaria · Humulin M3 (Mixture 3), Хумулин N
- Cyprus · Humulin M3
- Czechia · Humulin M3 (30/70) Cartridge, Humulin M3 (30/70) Kwikpen
- Germany · Huminsulin Basal (Nph), Huminsulin Basal (Nph) Kwikpen
- Denmark · Humulin Nph, Humulin Nph Kwikpen
- Estonia · Humulin N, Humulin N Kwikpen
- Spain · Humulina 30:70, Humulina 30:70 Kwikpen
- France · Umuline Nph, Umuline Nph Kwikpen
- United Kingdom (Northern Ireland) · Humulin I (Isophane), Humulin I Kwikpen (Isophane)
- Greece · Humulin M3, Humulin M3 Kwikpen
- Croatia · Humulin M3, Humulin N
- Hungary · Humulin M3 (30/70), Humulin N
- Ireland · Humulin I (Isophane), Humulin I Kwikpen (Isophane)
- Italy · Humulin 30/70 (Miscela), Humulin I (Isofano)
- Lithuania · Humulin N, Humulin N Kwikpen
- Luxembourg · Humuline 30/70 Cartridge, Humuline Nph Cartridge
- Latvia · Humulin N, Humulin N Kwikpen
- Malta · Humulin I (Isophane), Humulin M3 (Mixture 3)
- Netherlands · Humuline 30/70 Patroon, Humuline Nph Kwikpen
- Portugal · Humulin M3 (Mistura M3), Humulin Nph
- Romania · Humulin M3, Humulin M3 Kwikpen
- Sweden · Humulin Nph, Humulin Nph Kwikpen
- Slovenia · Humulin M3, Humulin M3 Kwikpen
- Slovakia · Humulin M3 (30/70) Cartridge, Humulin M3 (30/70) Kwikpen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b27745a5-88e4-47fb-ab32-801e8d72fbf0 GET /v1/drugs/b27745a5-88e4-47fb-ab32-801e8d72fbf0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "100",
"substance": "INSULIN HUMAN",
"productndc": "0002-8715",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"strength_unit": "[iU]/mL",
"application_number": "BLA019717",
"marketing_category": "BLA"
}See everything about insulin human.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.